+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2033

  • PDF Icon

    Report

  • 300 Pages
  • March 2024
  • Region: Global
  • Fairfield Market Research
  • ID: 5947328
The global drug delivery devices market is anticipated to witness substantial expansion over the coming decade, with projections indicating a surge from approximately US$35.4 billion in 2023 to a staggering US$90.2 billion by the end of 2033. This growth trajectory, representing a robust Compound Annual Growth Rate (CAGR) of 6.2% between 2023 and 2033, underscores significant opportunities and challenges within the industry.

Smart Drug Delivery Devices: Empowering Patients, Revolutionizing Healthcare

The market is experiencing a paradigm shift fueled by the rising adoption of smart drug delivery devices. These innovative technologies cater to patients' desire for enhanced control and convenience in healthcare management. With features such as automated dosing, reminders, and data tracking, smart devices not only improve medication adherence but also enable remote patient monitoring, particularly in the realm of telemedicine.

Navigating Regulatory Challenges: Balancing Innovation with Compliance

While the market showcases immense potential, regulatory hurdles pose significant barriers to entry and innovation. Lengthy approval processes by regulatory bodies like the US FDA and EMA delay market entry and deter companies from pursuing novel technologies. Addressing these challenges is crucial for fostering innovation and ensuring the timely introduction of patient-friendly and cost-efficient drug delivery devices.

Painless Alternatives Gain Momentum: Needle-Free Anaesthesia and Injectors on the Rise

A notable trend in the market is the increasing demand for painless and needle-free drug delivery solutions, particularly among pediatric and geriatric populations. Needle-free anaesthesia and injectors offer safe and effective alternatives to traditional methods, driving significant demand and reshaping the landscape of pain management in healthcare.

US FDA's Crucial Role: Safeguarding Safety and Effectiveness

The regulatory landscape, spearheaded by agencies like the US FDA, plays a pivotal role in ensuring the safety and effectiveness of medical devices. Compliance with stringent regulatory standards is essential for the development, approval, and market success of drug delivery devices, underscoring the importance of adherence to regulatory controls.

Insulin Pens Dominate: Convenience and Precision Enhance Patient Adherence

Insulin pens emerge as frontrunners in the market, offering unparalleled convenience, ease of use, and precise dosing. Their user-friendly design and reduced pain facilitate better patient adherence, ultimately leading to improved glycemic control and enhanced patient outcomes.

Disposable Devices Revolutionize Self-Administration: Convenience Meets Safety

Disposable drug delivery devices, characterized by convenience and safety, are witnessing increased adoption, particularly in self-administration scenarios. These devices eliminate the need for cleaning, minimizing the potential for medication errors and enhancing patient safety and treatment effectiveness.

Subcutaneous Delivery Surges: Catering to the Rise in Biologics and Patient Preferences

The preference for subcutaneous drug delivery is on the rise, driven by the increasing utilization of biologics and the growing demand for self-administration options. Subcutaneous delivery offers a less invasive and comfortable alternative, promoting patient compliance and driving the need for user-friendly delivery devices.

North America Leads Innovation: Technological Advancements and Stringent Regulations

North America emerges as a frontrunner in the global market, fueled by the region's focus on technological advancements, robust healthcare infrastructure, and adherence to stringent regulatory standards. Continuous innovations and investments in drug delivery technologies contribute to the region's prominence in the global landscape.

Competitive Analysis:

Manufacturers are constantly improving drug delivery devices, focusing on efficiency, safety, and patient convenience. They invest in innovative technologies like smart devices and biocompatible materials. Collaborations with pharmaceutical companies, research institutions, and technology firms accelerate product development and expand market reach.

Leaders in The Global Drug Delivery Devices Market including:

  • Eli Lilly and Company
  • Becton Dickinson And Co.
  • Novo Nordisk
  • Sanofi
  • Johnson & Johnson
  • Roche
  • Pfizer
  • AbbVie
  • Mylan N.V. (Viatris)
  • Insulet corporation
  • Medtronic Plc

Global Drug Delivery Devices Market Is Segmented as Below:

By Product:

  • Self-Injector
  • Single Chamber Self Injector
  • Dual Chamber Self Injector
  • Needle Free Injectors
  • Pre-Filled Needle Free Injectors
  • Fill-Able Needle Free Injectors
  • Auto-Injectors
  • Pre-Filled Auto-Injector
  • Fill-Able Auto-Injector
  • Wearable Injectors
  • Wearable Patch Injectors
  • Off-body Worn Injectors
  • Insulin Pens
  • Reusable Insulin Pens
  • Disposable Insulin Pens
  • Smart Insulin Pens
  • Implantable Drug Delivery
  • Contraceptive Implants
  • Intravitreal Implants
  • Buprenorphine Subdermal Implant
  • Implantable Infusion Pumps
  • Transdermal Patches
  • Drug in Adhesive Patches
  • Matrix Patches
  • Microneedle Patches
  • Reservoir Patches

By Usage:

  • Disposable Devices
  • Reusable Devices

By Route of Administration:

  • Transdermal
  • Subcutaneous
  • Intramuscular
  • Implantable

By Sales Channel:

  • Hospitals
  • Specialty Clinics
  • Retail Pharmacy Chains
  • Drug Stores
  • Online Sales Channel

By Application:

  • Diabetes
  • Anaphylaxis
  • Rheumatoid Arthritis
  • Cancer
  • Hormonal Therapy
  • Ophthalmology
  • Others

By Geographic Coverage:

  • North America
  • United States
  • Canada
  • Mexico
  • Latin America
  • Brazil
  • Chile
  • Rest of Latin America
  • Europe
  • Germany
  • Italy
  • France
  • U.K.
  • Spain
  • Benelux
  • Nordic Countries
  • Russia
  • Poland
  • Hungary
  • Balkan & Baltics
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • South Korea
  • India
  • Indonesia
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Middle East & Africa
  • Kingdom of Saudi Arabia
  • Other GCC Countries
  • Turkey
  • South Africa
  • Other African Union
  • Israel
  • Rest of Middle East and Africa

Table of Contents

1. Executive Summary
1.1. Global Drug Delivery Devices Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value and Volume, 2023
1.5. Analyst Recommendations
2. Market Overview
2.1. Market Definitions and Segmentations
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Market Opportunities
2.2.4. Supply
2.2.5. Demand
2.3. Forecast Factors - Relevance and Impact
2.4. Economic Overview
2.4.1. World Economic Projections
3. Value Added Insights
3.1. Promotional Strategies by Key Players
3.2. New Product Approvals/Launch
3.3. Parent Market Analysis, 2023
3.4. Value Chain Analysis
3.5. Porter’s Five Forces Analysis
3.6. COVID-19 Impact Analysis
3.7. PESTLE Analysis
4. Price Analysis, 2018 - 2023
4.1. Global Average Price Analysis, by Product, US$ Per Unit, 2018 - 2023
4.2. Prominent Factor Affecting Drug Delivery Devices Prices
4.3. Global Average Price Analysis, by Region, US$ Per Unit
5. Global Drug Delivery Devices Market Outlook, 2018 - 2033
5.1. Global Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
5.1.1. Key Highlights
5.1.1.1. Self-Injector
5.1.1.1.1. Single Chamber Self Injector
5.1.1.1.2. Dual Chamber Self Injector
5.1.1.2. Needle-Free Injectors
5.1.1.2.1. Pre-Filled Needle Free Injectors
5.1.1.2.2. Fill-Able Needle Free Injectors
5.1.1.3. Auto-Injectors
5.1.1.3.1. Pre-Filled Auto Injector
5.1.1.3.2. Fill-Able Auto Injector
5.1.1.4. Wearable Injectors
5.1.1.4.1. Wearable Patch Injectors
5.1.1.4.2. Off-body Worn Injectors
5.1.1.5. Insulin Pens
5.1.1.5.1. Reusable Insulin Pens
5.1.1.5.2. Disposable Insulin Pens
5.1.1.5.3. Smart Insulin Pens
5.1.1.6. Implantable Drug Delivery
5.1.1.6.1. Contraceptive Implants
5.1.1.6.2. Intravitreal Implants
5.1.1.6.3. Buprenorphine Subdermal Implant
5.1.1.6.4. Implantable Infusion Pumps
5.1.1.7. Transdermal Patches
5.1.1.7.1. Drug in Adhesive Patches
5.1.1.7.2. Matrix Patches
5.1.1.7.3. Microneedle Patches
5.1.1.7.4. Reservoir Patches
5.2. Global Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn)
5.2.1. Key Highlights
5.2.1.1. Disposable Devices
5.2.1.2. Reusable Devices
5.3. Global Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2033
5.3.1. Key Highlights
5.3.1.1. Transdermal
5.3.1.2. Subcutaneous
5.3.1.3. Intramuscular
5.3.1.4. Implantable
5.4. Global Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2033
5.4.1. Key Highlights
5.4.1.1. Hospitals
5.4.1.2. Specialty Clinics
5.4.1.3. Retail Pharmacy Chains
5.4.1.4. Drug Stores
5.4.1.5. Online Sales Channel
5.5. Global Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
5.5.1. Key Highlights
5.5.1.1. Diabetes
5.5.1.2. Anaphylaxis
5.5.1.3. Rheumatoid Arthritis
5.5.1.4. Cancer
5.5.1.5. Hormonal Therapy
5.5.1.6. Ophthalmology
5.5.1.7. Others
5.6. Global Drug Delivery Devices Market Outlook, by Region, Value (US$ Bn) , 2018 - 2033
5.6.1. Key Highlights
5.6.1.1. North America
5.6.1.2. Latin America
5.6.1.3. Europe
5.6.1.4. Asia Pacific
5.6.1.5. Middle East & Africa
6. North America Drug Delivery Devices Market Outlook, 2018 - 2033
6.1. North America Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
6.1.1. Key Highlights
6.1.1.1. Self-Injector
6.1.1.1.1. Single Chamber Self Injector
6.1.1.1.2. Dual Chamber Self Injector
6.1.1.2. Needle Free Injectors
6.1.1.2.1. Pre-Filled Needle Free Injectors
6.1.1.2.2. Fill-Able Needle Free Injectors
6.1.1.3. Auto Injectors
6.1.1.3.1. Pre-Filled Auto Injector
6.1.1.3.2. Fill-Able Auto Injector
6.1.1.4. Wearable Injectors
6.1.1.4.1. Wearable Patch Injectors
6.1.1.4.2. Off-body Worn Injectors
6.1.1.5. Insulin Pens
6.1.1.5.1. Reusable Insulin Pens
6.1.1.5.2. Disposable Insulin Pens
6.1.1.5.3. Smart Insulin Pens
6.1.1.6. Implantable Drug Delivery
6.1.1.6.1. Contraceptive Implants
6.1.1.6.2. Intravitreal Implants
6.1.1.6.3. Buprenorphine Subdermal Implant
6.1.1.6.4. Implantable Infusion Pumps
6.1.1.7. Transdermal Patches
6.1.1.7.1. Drug in Adhesive Patches
6.1.1.7.2. Matrix Patches
6.1.1.7.3. Microneedle Patches
6.1.1.8. Reservoir Patches
6.2. North America Drug Delivery Devices Market Outlook, by Usage, Value (US$ Bn), 2018 - 2033
6.2.1. Key Highlights
6.2.1.1. Disposable Devices
6.2.1.2. Reusable Devices
6.3. North America Drug Delivery Devices Market Outlook, by Route of Administration, Value (US$ Bn), 2018 - 2033
6.3.1. Key Highlights
6.3.1.1. Transdermal
6.3.1.2. Subcutaneous
6.3.1.3. Intramuscular
6.3.1.4. Implantable
6.4. North America Drug Delivery Devices Market Outlook, by Sales Channel, Value (US$ Bn), 2018 - 2033
6.4.1. Key Highlights
6.4.1.1. Hospitals
6.4.1.2. Specialty Clinics
6.4.1.3. Retail Pharmacy Chains
6.4.1.4. Drug Stores
6.4.1.5. Online Sales Channel
6.5. North America Drug Delivery Devices Market Outlook, by Application, Value (US$ Bn), 2018 - 2033
6.5.1. Key Highlights
6.5.1.1. Diabetes
6.5.1.2. Anaphylaxis
6.5.1.3. Rheumatoid Arthritis
6.5.1.4. Cancer
6.5.1.5. Hormonal Therapy
6.5.1.6. Ophthalmology
6.5.1.7. Others
6.5.2. BPS Analysis/Market Attractiveness Analysis
6.6. North America Drug Delivery Devices Market Share Analysis (%) Outlook, by Country, 2023 & 2033
6.6.1. Key Highlights
6.6.2. BPS Analysis/Market Attractiveness Analysis
7. Latin America Drug Delivery Devices Market Outlook, 2018 - 2033
7.1. Latin America Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
7.1.1. Key Highlights
7.1.1.1. Self-Injector
7.1.1.1.1. Single Chamber Self Injector
7.1.1.1.2. Dual Chamber Self Injector
7.1.1.2. Needle Free Injectors
7.1.1.2.1. Pre-Filled Needle Free Injectors
7.1.1.2.2. Fill-Able Needle Free Injectors
7.1.1.3. Auto Injectors
7.1.1.3.1. Pre-Filled Auto Injector
7.1.1.3.2. Fill-Able Auto Injector
7.1.1.4. Wearable Injectors
7.1.1.4.1. Wearable Patch Injectors
7.1.1.4.2. Off-body Worn Injectors
7.1.1.5. Insulin Pens
7.1.1.5.1. Reusable Insulin Pens
7.1.1.5.2. Disposable Insulin Pens
7.1.1.5.3. Smart Insulin Pens
7.1.1.6. Implantable Drug Delivery
7.1.1.6.1. Contraceptive Implants
7.1.1.6.2. Intravitreal Implants
7.1.1.6.3. Buprenorphine Subdermal Implant
7.1.1.6.4. Implantable Infusion Pumps
7.1.1.7. Transdermal Patches
7.1.1.7.1. Drug in Adhesive Patches
7.1.1.7.2. Matrix Patches
7.1.1.7.3. Microneedle Patches
7.1.1.8. Reservoir Patches
7.2. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
7.2.1.1. Disposable Devices
7.2.1.2. Reusable Devices
7.3. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
7.3.1. Key Highlights
7.3.1.1. Transdermal
7.3.1.2. Subcutaneous
7.3.1.3. Intramuscular
7.3.1.4. Implantable
7.4. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
7.4.1. Key Highlights
7.4.1.1. Hospitals
7.4.1.2. Specialty Clinics
7.4.1.3. Retail Pharmacy Chains
7.4.1.4. Drug Stores
7.4.1.5. Online Sales Channel
7.5. Latin America Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
7.5.1. Key Highlights
7.5.1.1. Diabetes
7.5.1.2. Anaphylaxis
7.5.1.3. Rheumatoid Arthritis
7.5.1.4. Cancer
7.5.1.5. Hormonal Therapy
7.5.1.6. Ophthalmology
7.5.1.7. Others
7.5.2. BPS Analysis/Market Attractiveness Analysis
7.6. Latin America Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
7.6.1. Key Highlights
7.6.2. BPS Analysis/Market Attractiveness Analysis
8. Europe Drug Delivery Devices Market Outlook, 2018 - 2033
8.1. Europe Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
8.1.1. Key Highlights
8.1.1.1. Self-Injector
8.1.1.1.1. Single Chamber Self Injector
8.1.1.1.2. Dual Chamber Self Injector
8.1.1.2. Needle Free Injectors
8.1.1.2.1. Pre-Filled Needle Free Injectors
8.1.1.2.2. Fill-Able Needle Free Injectors
8.1.1.3. Auto Injectors
8.1.1.3.1. Pre-Filled Auto Injector
8.1.1.3.2. Fill-Able Auto Injector
8.1.1.4. Wearable Injectors
8.1.1.4.1. Wearable Patch Injectors
8.1.1.4.2. Off-body Worn Injectors
8.1.1.5. Insulin Pens
8.1.1.5.1. Reusable Insulin Pens
8.1.1.5.2. Disposable Insulin Pens
8.1.1.5.3. Smart Insulin Pens
8.1.1.6. Implantable Drug Delivery
8.1.1.6.1. Contraceptive Implants
8.1.1.6.2. Intravitreal Implants
8.1.1.6.3. Buprenorphine Subdermal Implant
8.1.1.6.4. Implantable Infusion Pumps
8.1.1.7. Transdermal Patches
8.1.1.7.1. Drug in Adhesive Patches
8.1.1.7.2. Matrix Patches
8.1.1.7.3. Microneedle Patches
8.1.1.8. Reservoir Patches
8.2. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
8.2.1. Key Highlights
8.2.1.1. Disposable Devices
8.2.1.2. Reusable Devices
8.3. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
8.3.1. Key Highlights
8.3.1.1. Transdermal
8.3.1.2. Subcutaneous
8.3.1.3. Intramuscular
8.3.1.4. Implantable
8.4. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
8.4.1. Key Highlights
8.4.1.1. Hospitals
8.4.1.2. Specialty Clinics
8.4.1.3. Retail Pharmacy Chains
8.4.1.4. Drug Stores
8.4.1.5. Online Sales Channel
8.5. Europe Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
8.5.1. Key Highlights
8.5.1.1. Diabetes
8.5.1.2. Anaphylaxis
8.5.1.3. Rheumatoid Arthritis
8.5.1.4. Cancer
8.5.1.5. Hormonal Therapy
8.5.1.6. Ophthalmology
8.5.1.7. Others
8.5.2. BPS Analysis/Market Attractiveness Analysis
8.6. Europe Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
8.6.1. Key Highlights
9. Asia Pacific Drug Delivery Devices Market Outlook, 2018 - 2033
9.1. Asia Pacific Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
9.1.1. Key Highlights
9.1.1.1. Self-Injector
9.1.1.1.1. Single Chamber Self Injector
9.1.1.1.2. Dual Chamber Self Injector
9.1.1.2. Needle Free Injectors
9.1.1.2.1. Pre-Filled Needle Free Injectors
9.1.1.2.2. Fill-Able Needle Free Injectors
9.1.1.3. Auto Injectors
9.1.1.3.1. Pre-Filled Auto Injector
9.1.1.3.2. Fill-Able Auto Injector
9.1.1.4. Wearable Injectors
9.1.1.4.1. Wearable Patch Injectors
9.1.1.4.2. Off-body Worn Injectors
9.1.1.5. Insulin Pens
9.1.1.5.1. Reusable Insulin Pens
9.1.1.5.2. Disposable Insulin Pens
9.1.1.5.3. Smart Insulin Pens
9.1.1.6. Implantable Drug Delivery
9.1.1.6.1. Contraceptive Implants
9.1.1.6.2. Intravitreal Implants
9.1.1.6.3. Buprenorphine Subdermal Implant
9.1.1.6.4. Implantable Infusion Pumps
9.1.1.7. Transdermal Patches
9.1.1.7.1. Drug in Adhesive Patches
9.1.1.7.2. Matrix Patches
9.1.1.7.3. Microneedle Patches
9.1.1.8. Reservoir Patches
9.2. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
9.2.1. Key Highlights
9.2.1.1. Disposable Devices
9.2.1.2. Reusable Devices
9.3. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
9.3.1. Key Highlights
9.3.1.1. Transdermal
9.3.1.2. Subcutaneous
9.3.1.3. Intramuscular
9.3.1.4. Implantable
9.4. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
9.4.1. Key Highlights
9.4.1.1. Hospitals
9.4.1.2. Specialty Clinics
9.4.1.3. Retail Pharmacy Chains
9.4.1.4. Drug Stores
9.4.1.5. Online Sales Channel
9.5. Asia Pacific Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
9.5.1. Key Highlights
9.5.1.1. Diabetes
9.5.1.2. Anaphylaxis
9.5.1.3. Rheumatoid Arthritis
9.5.1.4. Cancer
9.5.1.5. Hormonal Therapy
9.5.1.6. Ophthalmology
9.5.1.7. Others
9.5.2. BPS Analysis/Market Attractiveness Analysis
9.6. Asia Pacific Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
9.6.1. Key Highlights
9.6.2. BPS Analysis/Market Attractiveness Analysis
10. Middle East & Africa Drug Delivery Devices Market Outlook, 2018 - 2033
10.1. Middle East & Africa Drug Delivery Devices Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2018 - 2033
10.1.1. Key Highlights
10.1.1.1. Self-Injector
10.1.1.1.1. Single Chamber Self Injector
10.1.1.1.2. Dual Chamber Self Injector
10.1.1.2. Needle Free Injectors
10.1.1.2.1. Pre-Filled Needle Free Injectors
10.1.1.2.2. Fill-Able Needle Free Injectors
10.1.1.3. Auto Injectors
10.1.1.3.1. Pre-Filled Auto Injector
10.1.1.3.2. Fill-Able Auto Injector
10.1.1.4. Wearable Injectors
10.1.1.4.1. Wearable Patch Injectors
10.1.1.4.2. Off-body Worn Injectors
10.1.1.5. Insulin Pens
10.1.1.5.1. Reusable Insulin Pens
10.1.1.5.2. Disposable Insulin Pens
10.1.1.5.3. Smart Insulin Pens
10.1.1.6. Implantable Drug Delivery
10.1.1.6.1. Contraceptive Implants
10.1.1.6.2. Intravitreal Implants
10.1.1.6.3. Buprenorphine Subdermal Implant
10.1.1.6.4. Implantable Infusion Pumps
10.1.1.7. Transdermal Patches
10.1.1.7.1. Drug in Adhesive Patches
10.1.1.7.2. Matrix Patches
10.1.1.7.3. Microneedle Patches
10.1.1.8. Reservoir Patches
10.2. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Usage, 2023 & 2033
10.2.1. Key Highlights
10.2.1.1. Disposable Devices
10.2.1.2. Reusable Devices
10.3. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Route of Administration, 2023 & 2033
10.3.1. Key Highlights
10.3.1.1. Transdermal
10.3.1.2. Subcutaneous
10.3.1.3. Intramuscular
10.3.1.4. Implantable
10.4. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Sales Channel, 2023 & 2033
10.4.1. Key Highlights
10.4.1.1. Hospitals
10.4.1.2. Specialty Clinics
10.4.1.3. Retail Pharmacy Chains
10.4.1.4. Drug Stores
10.4.1.5. Online Sales Channel
10.5. Middle East & Africa Drug Delivery Devices Market Outlook, Share Analysis (%) Outlook, by Application, 2023 & 2033
10.5.1. Key Highlights
10.5.1.1. Diabetes
10.5.1.2. Anaphylaxis
10.5.1.3. Rheumatoid Arthritis
10.5.1.4. Cancer
10.5.1.5. Hormonal Therapy
10.5.1.6. Ophthalmology
10.5.1.7. Others
10.5.2. BPS Analysis/Market Attractiveness Analysis
10.6. Middle East & Africa Drug Delivery Devices Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2018 - 2033
10.6.1. Key Highlights
10.6.2. BPS Analysis/Market Attractiveness Analysis
11. Competitive Landscape
11.1. Company Market Share Analysis, 2023
11.2. Competitive Dashboard
11.3. Company Profiles
11.3.1. Eli Lilly and Company
11.3.1.1. Company Overview
11.3.1.2. Product Portfolio
11.3.1.3. Financial Overview
11.3.1.4. Business Strategies and Development
11.3.2. Becton Dickinson And Co.
11.3.2.1. Company Overview
11.3.2.2. Product Portfolio
11.3.2.3. Financial Overview
11.3.2.4. Business Strategies and Development
11.3.3. Novo Nordisk
11.3.3.1. Company Overview
11.3.3.2. Product Portfolio
11.3.3.3. Financial Overview
11.3.3.4. Business Strategies and Development
11.3.4. Sanofi
11.3.4.1. Company Overview
11.3.4.2. Product Portfolio
11.3.4.3. Financial Overview
11.3.4.4. Business Strategies and Development
11.3.5. Johnson & Johnson
11.3.5.1. Company Overview
11.3.5.2. Product Portfolio
11.3.5.3. Financial Overview
11.3.5.4. Business Strategies and Development
11.3.6. Roche
11.3.6.1. Company Overview
11.3.6.2. Product Portfolio
11.3.6.3. Financial Overview
11.3.6.4. Business Strategies and Development
11.3.7. Pfizer
11.3.7.1. Company Overview
11.3.7.2. Product Portfolio
11.3.7.3. Financial Overview
11.3.7.4. Business Strategies and Development
11.3.8. AbbVie
11.3.8.1. Company Overview
11.3.8.2. Product Portfolio
11.3.8.3. Financial Overview
11.3.8.4. Business Strategies and Development
11.3.9. Mylan N.V. (Viatris)
11.3.9.1. Company Overview
11.3.9.2. Product Portfolio
11.3.9.3. Financial Overview
11.3.9.4. Business Strategies and Development
11.3.10. Insulet corporation
11.3.10.1. Company Overview
11.3.10.2. Product Portfolio
11.3.10.3. Financial Overview
11.3.10.4. Business Strategies and Development
11.3.11. Medtronic plc
11.3.11.1. Company Overview
11.3.11.2. Product Portfolio
11.3.11.3. Financial Overview
11.3.11.4. Business Strategies and Development
11.3.12. Others
12. Appendix
12.1. Research Methodology
12.2. Report Assumptions
12.3. Acronyms and Abbreviations

Companies Mentioned

  • Eli Lilly and Company
  • Becton Dickinson And Co.
  • Novo Nordisk
  • Sanofi
  • Johnson & Johnson
  • Roche
  • Pfizer
  • AbbVie
  • Mylan N.V. (Viatris)
  • Insulet corporation
  • Medtronic Plc

Methodology

Loading
LOADING...